Adoption of Global Quality Standards is required for Indian Pharma: OPPI

OPPI stands for the Organisation of Pharmaceutical Producers of India and it represents the research-based pharmaceutical companies in India. It completely engages with the government and other stakeholders to find the best sustainable healthcare solutions.

According to OPPI, Indian pharma required to adopt global quality standards to gain the growth of the sector and bring all stakeholders like regulators, industry, and governments to work jointly towards it.

WHO (World Health Organisation) has set some quality standards like GMP(Good Manufacturing Practices) and Indian pharma should need to maintain uniform baseline with them. Kanchana, OPPI director general said that the medicine making process should follow the global standards and need to implement from initial manufacturing stage to the delivery chain.

To address the quality issues in the pharmaceutical industry, all the government officials, industry representatives, industry associations and patient groups met in the Summit. All were discussed about the gamut of issues covering quality, ranging from labeling to packaging and storage at the summit.

Uttar Pradesh Department of Food Safety and Drug Administration study reports that around 38% of medicines are not effective as they are the outcome of low-quality standards. India has a number of pharmaceutical manufacturing industries but no quality standards maintained across the board.

To raise manufacturing quality standards, the government need to work with industry associations and other stakeholders including patient groups that represent the public and have to work together. That step will keep India globally competitive and Indian drugs sought after in global markets. Challenges like regulatory issues need to be addressed on the urgent basis for the growth of the Indian pharmaceutical industry.

Kanchana also commented on Government policies that policies should be more predictable and should remain for 3-5 years and Pharma Industry is in the need to have progressive policy changes.

OPPI just want to convey the importance of quality in delivering responsible and safe patient care as the quality of the medicine also plays an important role in cure process.

Related Posts

Zydus Lifesciences Q4FY26 net profit rises 9%

Zydus board approved a buyback of up to Rs 1100 crore at Rs 1,150 per share, along with a 100 percent dividend for FY26. Zydus Lifesciences reported a rise in…

Chemists strike on May 20: Reasons behind today’s all-India strike

While major pharmacy chains and government medical outlets will remain operational, the strike highlights significant tensions within the industry that could impact access to medications nationwide. The All India Organisation…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Zydus Lifesciences Q4FY26 net profit rises 9%

Zydus Lifesciences Q4FY26 net profit rises 9%

Chemists strike on May 20: Reasons behind today’s all-India strike

Chemists strike on May 20: Reasons behind today’s all-India strike

AbbVie loses patent plea for Hep C drug

AbbVie loses patent plea for Hep C drug

GSK’s Calpol a well-known trademark: High Court

GSK’s Calpol a well-known trademark: High Court

3 arrested for allegedly posing as doctors using forged MBBS degrees

3 arrested for allegedly posing as doctors using forged MBBS degrees

Commissioner FDA reviews enforcement measures

Commissioner FDA reviews enforcement measures